Speaker

Press releases

5/3/2023 6:30 AM

Strong growth in the first quarter – adjusted EBITDA up 33 percent

Regulatory Interim report

Läs mer

2/10/2023 6:30 AM

Strong organic growth in both the quarter and the year

Regulatory Interim report

Läs mer

1/10/2023 2:30 PM

MedCap AB (publ) announces the final outcome in its recommended cash offer to the shareholders of AdderaCare

Regulatory

Läs mer

12/27/2022 2:30 PM

MedCap announces the final outcome in its recommended cash offer to the shareholders of AdderaCare

Regulatory

Läs mer

12/23/2022 8:00 PM

MedCap completes the recommended cash offer to the shareholders of AdderaCare and extends the acceptance period

Regulatory

Läs mer

12/1/2022 8:30 AM

Offer document regarding the offer to the shareholders of AdderaCare made public

Regulatory

Läs mer

11/17/2022 7:45 AM

MedCap AB (publ) announces a recommended cash offer at a price of SEK 3.60 per share to the shareholders of AdderaCare AB (publ)

Regulatory

Läs mer

10/28/2022 6:30 AM

Sales and earnings growth – EBITDA increased by 32%

Regulatory Interim report

Läs mer

7/29/2022 6:30 AM

A strong quarter throughout the Group - EBITDA increased by 29 percent

Regulatory Interim report

Läs mer

7/22/2022 8:30 AM

MedCap divests Vitamin D

Läs mer

1
2
3
4